Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RYTM
#1020
Rhythm Pharmaceuticals, Inc. Common Stock
92.730
0
-4.28%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-4.28%
Monatliche Änderung
-11.82%
6 month change
-15.94%
Jahresänderung
-15.94%
Vorheriger Schlusskurs
96.880
0
Open
92.830
0
Bid
Ask
Low
92.730
0
High
92.830
0
Volumen
161
Märkte
Aktien
Gesundheitswesen
RYTM
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
61.46 M
63.22 M
63.62 M
66.42 M
66.74 M
68.29 M
—
Valuation ratios
Enterprise value
3.17 B
3.45 B
3.26 B
4.06 B
6.69 B
7.25 B
21.27 B
Price to earnings ratio
141.37
-12.9
-18.92
-21.06
-32.68
-34.42
-107.08
Price to sales ratio
27.99
26.24
23.82
25.18
36.86
36.66
122.51
Price to cash flow ratio
25.24
29.98
28.83
36.59
58.83
60.13
184.39
Price to book ratio
10.93
157.14
35.68
61.54
32.69
50.02
179.92
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.11
0.13
0.13
0.1
0.1
0.46
Return on equity %
3.89
1.99
2.61
3.92
0.36
0.34
7.23
Return on invested capital %
397.03
280.37
323.67
206.59
200.79
328.63
1 059.69
Gross margin %
88.49
90.95
88.85
88.57
89.28
91.61
358.31
Operating margin %
131.98
98.62
143.73
93.39
102.64
82.2
421.96
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
131.36
103.5
151.35
96.14
103.13
82.97
433.6
Liquidity ratios
Quick ratio
3.34
3.08
3.13
2.64
4.53
4.16
14.47
Current ratio
3.49
3.24
3.3
2.79
4.75
4.41
15.24
Inventory turnover
0.3
0.23
0.19
0.29
0.27
0.2
0.95
Asset turnover
0.09
0.11
0.08
0.13
0.12
0.12
0.44
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.28
0.28
0.28
0.2
0.21
0.98
Long term debt to total equity ratio
—
4.98
5.7
8.9
0.69
0.73
16.02
Per share metrics
Operating cash flow per share
0.41
0.31
0.64
0.37
0.4
0.39
1.8
EBIT per share
-0.72
-0.68
-0.75
-0.71
-0.79
-0.72
-2.98
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.87
5.26
4.99
4.57
6.28
5.98
21.82
Net current asset value per share
5.56
6.13
5.86
5.66
7.47
7.19
26.17
Tangible book value per share
0.08
0.26
0.21
0.1
2.16
2.06
4.52
Working capital per share
3.96
4.24
4.08
3.63
5.89
5.55
19.16
Book value per share
0.18
0.36
0.3
0.19
2.25
2.14
4.87
Nachrichten
Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance
Citizens eleva preço-alvo da Rhythm Pharmaceuticals com expectativa de aprovação
Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook
Stifel reitera recomendação de compra para Rhythm Pharmaceuticals com preço-alvo de US$ 131
Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Rhythm Pharma supera expectativas de receita no 4º tri de 2025
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears
Lucro da Rhythm Pharma superou projeções por $0,09; receita supera estimativas
Rhythm Pharma earnings beat by $0.09, revenue topped estimates
Resultados da Rhythm Pharma em foco antes de aprovação crucial para obesidade
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?